P-ISSN 2587-2400 | E-ISSN 2587-196X

Volume: 4 Issue: 4 - 2020

Various Evidence-Based Hypothetical and Experimental Treatment Approaches and Their Effectiveness against COVID-19 Worldwide: A Comprehensive Literature Review
Muhammad Naveed, Shahab Uddin, Khaldoon S. Abdullah, Sidra Erum Ishaq, Tariq Ahmad
doi: 10.14744/ejmo.2020.52538   Pages  265 -  285 
(Viewed: 6650)

Evaluation of the Relationship between Antioxidant Gene Polymorphisms (Endothelial Nitric Oxide Synthase, Myeloperoxidase, Uncoupling Protein 2) and Breast Cancer
Dilek Erdem, Meral Gunaldi, Nilgun Isiksacan, Irem Karaman, Mustafa Pehlivan, Sacide Pehlivan
doi: 10.14744/ejmo.2020.99886   Pages  286 -  291 
(Viewed: 1293)

Expression of Myeloid Cell Leukemia-1 (Mcl-1) Predicts the Survival of Patients with Metastatic Gastric Cancer
Esma Turkmen Bekmez, Gulsah Safak Orkan
doi: 10.14744/ejmo.2020.17777   Pages  292 -  298 
(Viewed: 1077)

Comparison of Two Different Antibody Clones of Programmed Cell Death Ligand 1 (PD-L1) with Immunohistochemical Method on Various Tumors
Fatma Tokat
doi: 10.14744/ejmo.2020.44540   Pages  299 -  303 
(Viewed: 1294)

Design of CRISPR-Based Targets for the Development of a Diagnostic Method for SARS-CoV-2: An in Silico Approach
Abraham Peele Karlapudi, Chinna Venkateswarulu Thirupati, Krupanidhi Srirrama, Divyashree Coimbatore Nageswaran, Indira Mikkili,, Vijayasai Sai Ayyagari, Ranganadha Reddy Reddy Aluri, Yasha Nazir Butt, Aishwarya Gangadhar
doi: 10.14744/ejmo.2020.70579   Pages  304 -  308 
(Viewed: 2808)

Mutated USP9X-Associated TRIM33 Inhibition in the Metastasis of Gingivobuccal Oral Squamous Cell Carcinoma
Suchitra Singh, Ajay Kumar Singh
doi: 10.14744/ejmo.2020.70327   Pages  309 -  318 
(Viewed: 1573)

Screening of Preferential Binding Affinity of Selected Natural Compounds to SARS-CoV-2 Proteins Using in Silico Methods
Nikolina Tomic, Lejla Pojskic, Abdurahim Kalajdzic, Jasmin Ramic, Naida Lojo Kadric, Tarik Ikanovic, Milka Maksimovic, Naris Pojskic
doi: 10.14744/ejmo.2020.72548   Pages  319 -  323 
(Viewed: 3421)

Molecular Docking Study of Some Nucleoside Analogs against Main Protease of SARS-CoV-2
Abhijit Chhetria, Dhiraj Brahman
doi: 10.14744/ejmo.2020.94995   Pages  324 -  335 
(Viewed: 2368)

In Silico Identification of Potential Inhibitors of the Main Protease of SARS-CoV-2 Using Combined Ligand-Based and Structure-Based Drug Design Approach
Bimal Debnath, Apu Kr Saha, Samhita Bhaumik, Sudhan Debnath
doi: 10.14744/ejmo.2020.91768   Pages  336 -  348 
(Viewed: 2403)

The Pain of Sending Away Cancer Patients Amidst the COVID-19 Pandemic in Philippines
Frederic Ivan Ting, Aveline Marie Ylanan, Dennis Lee Sacdalan
doi: 10.14744/ejmo.2020.50870   Pages  349 -  350 
(Viewed: 4711)

Preoperative Evaluation: Could age be the Only Risk Factor Toward Requiring Further Diagnostic Investigations?
Antonio Coviello, Danilo Esposito, Roberta Galletta, Marilena Ianniello, Alfredo Maresca, Giuseppe Servillo
doi: 10.14744/ejmo.2020.79579   Pages  351 -  352 
(Viewed: 1918)

SARS-CoV-2 Related Protein Expression May Predict Vulnerability for Developing COVID-19 in Cancer Patients
Ashutosh Kumar, Ravi K Narayan, Vikas Pareek, Chiman Kumari
doi: 10.14744/ejmo.2020.73771   Pages  353 -  354 
(Viewed: 1631)


  • Impact Factor: 2.5

  • Medicine, General & Internal: Q2 146/322

  • SCOPUS click

  • CiteScoreTracker 2023: 3.6
  • CiteScore year 2022:
  • CiteScore year 2021:

  • Google Scholar click

  • Number of Articles:315
  • Citations:2587
  • h-index:16
  • i10-index:=26

  • EJMO NLM ID: 101720527

  • Accept Ratio :18.2 %
  • Final decision avg 34 day